News
4 Apr 2016
Healthcare
- These proteins are potential biomarkers that could be used to predict the best treatment for each patient
- They analyzed the differences in protein modulation between patients responding to celecoxib or to the combination of chondroitin sulfate and hydrochlorure of glucosamine, and patients not responding to these treatments.
11 Mar 2016
Healthcare
- Bioibérica has developed an algorithm to calculate joint age, considering the risk factors that lead to wear and tear
- Participants answer a questionnaire and can choose to complete it with an on-site scan by a specialised sports-medicine physician
- It is calculated that, on average, marathon runners’ joints are 5 years older than their biological age
3 Mar 2016
Healthcare
The company’s Human Health Division will hold a number of meetings during this event, the largest in the world in the field of natural, organic and healthy products
19 Feb 2016
Healthcare
- Women suffering from osteoarthritis also have a 70% higher rate of hypertension and a 114% higher rate of peripheral vascular disease than women not suffering from osteoarthritis.
- Specialists point out the importance of taking into account these specific factors in women before deciding the best therapeutic approach for osteoarthritis.
10 Nov 2015
Healthcare
- This is the main conclusion of a new clinical essay that proved, by means of Quantitative Magnetic Resonance, that pharmaceutical grade chondroitin sulfate is superior to an anti-inflammatory drug (celecoxib) for delaying the disease’s progression